Name: UMIN ID:
Unique ID issued by UMIN | UMIN000016029 |
---|---|
Receipt number | R000018636 |
Scientific Title | Phase I study of afatinib + bevacizumab for advanced NSCLC with EGFR mutation |
Date of disclosure of the study information | 2014/12/22 |
Last modified on | 2018/12/25 18:41:16 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/12/22 16:04:47 | ||
2 | Update | 2015/06/22 10:37:43 | Recruitment status |
|
3 | Update | 2017/06/25 00:40:15 | Name of primary person or sponsor Institute Organization Organization |
|
4 | Update | 2018/12/25 18:41:16 | Recruitment status |